FDA's 'de-identified and masked' data plan is threat to trade secrets, says US devices industry
This article was originally published in SRA
Executive Summary
The US medical devices industry has found major fault with the Food and Drug Administration’s proposal to make available to the public de-identified and masked data derived from medical product applications1.